|
|
||||||||
1 Department of Pharmacology, New York Medical College, Valhalla, New York 10595; and 2 Departments of Biochemistry and Pharmacology, University of Texas Southwestern Medical Center, Dallas, Texas 75235
20-HETE, a cytochrome
P-450 4A (CYP4A1)-derived arachidonic acid metabolite,
is a major eicosanoid formed in renal and extrarenal microcirculation.
20-HETE inhibits Ca2+-activated K+ channels in
vascular smooth muscle cells and thereby may modulate vascular
reactivity. We transfected renal interlobar arteries with an expression
plasmid containing the cDNA of CYP4A1, the low-Km arachidonic acid
-hydroxylase, and
examined the consequences of increasing 20-HETE synthesis on
constrictor responses to phenylephrine. CYP4A1-transfected interlobar
arteries demonstrated a twofold increase in CYP4A protein levels and
20-HETE production compared with arteries transfected with the empty
plasmid; they also showed increased sensitivity to phenylephrine, as
evidenced by a decrease in EC50 from 0.37 ± 0.04 µM
in plasmid-transfected arteries to 0.07 ± 0.01 µM in
CYP4A1-transfected arteries. The increased sensitivity to phenylephrine
was greatly attenuated by
N-methylsulfonyl-12,12-dibromododec-11-enamide (DDMS),
a selective inhibitor of 20-HETE synthesis, and by
20-hydroxyeicosa-6(Z),15(Z)-dienoic acid, a
specific 20-HETE antagonist. This effect of DDMS was reversed by
addition of 20-HETE, further substantiating the notion that increased
levels of 20-HETE contribute to the increased sensitivity to
phenylephrine in vessels overexpressing CYP4A1. These data suggest that
20-HETE of vascular origin sensitizes renal vascular smooth muscle to phenylephrine.
20-hydroxyeicosatetraenoic acid; arachidonic acid; phenylephrine; cytochrome P-450
This article has been cited by other articles:
![]() |
J. Cheng, J.-S. Ou, H. Singh, J. R. Falck, D. Narsimhaswamy, K. A. Pritchard Jr., and M. L. Schwartzman 20-Hydroxyeicosatetraenoic acid causes endothelial dysfunction via eNOS uncoupling Am J Physiol Heart Circ Physiol, February 1, 2008; 294(2): H1018 - H1026. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Singh, J. Cheng, H. Deng, R. Kemp, T. Ishizuka, A. Nasjletti, and M. L. Schwartzman Vascular Cytochrome P450 4A Expression and 20-Hydroxyeicosatetraenoic Acid Synthesis Contribute to Endothelial Dysfunction in Androgen-Induced Hypertension Hypertension, July 1, 2007; 50(1): 123 - 129. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. L. Jernigan and H. A. Drummond Myogenic vasoconstriction in mouse renal interlobar arteries: role of endogenous beta and {gamma}ENaC Am J Physiol Renal Physiol, December 1, 2006; 291(6): F1184 - F1191. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-S. Wang, H. Singh, F. Zhang, T. Ishizuka, H. Deng, R. Kemp, M. S. Wolin, T. H. Hintze, N. G. Abraham, A. Nasjletti, et al. Endothelial Dysfunction and Hypertension in Rats Transduced With CYP4A2 Adenovirus Circ. Res., April 14, 2006; 98(7): 962 - 969. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Zhang, H. Deng, R. Kemp, H. Singh, V. R. Gopal, J. R. Falck, M. Laniado-Schwartzman, and A. Nasjletti Decreased Levels of Cytochrome P450 2E1-Derived Eicosanoids Sensitize Renal Arteries to Constrictor Agonists in Spontaneously Hypertensive Rats Hypertension, January 1, 2005; 45(1): 103 - 108. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-S. Wang, F. Zhang, M. Jiang, M.-H. Wang, B. A. Zand, N. G. Abraham, A. Nasjletti, and M. Laniado-Schwartzman Transfection and Functional Expression of CYP4A1 and CYP4A2 Using Bicistronic Vectors in Vascular Cells and Tissues J. Pharmacol. Exp. Ther., December 1, 2004; 311(3): 913 - 920. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Zhang, M.-H. Wang, J.-S. Wang, B. Zand, V. R. Gopal, J. R. Falck, M. Laniado-Schwartzman, and A. Nasjletti Transfection of CYP4A1 cDNA decreases diameter and increases responsiveness of gracilis muscle arterioles to constrictor stimuli Am J Physiol Heart Circ Physiol, September 1, 2004; 287(3): H1089 - H1095. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-I. Kaide, F. Zhang, Y. Wei, W. Wang, V. R. Gopal, J. R. Falck, M. Laniado-Schwartzman, and A. Nasjletti Vascular CO Counterbalances the Sensitizing Influence of 20-HETE on Agonist-Induced Vasoconstriction Hypertension, August 1, 2004; 44(2): 210 - 216. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |